John Boslego

John Boslego, MD has worked for more than 40 years in vaccine clinical research and development. Dr. Boslego was most recently Senior Vice President and Head of Development for Takeda’s Global Vaccine Business Unit. Prior to Takeda, he was Director of the Vaccine Development Global Program at PATH, where he built a vaccine development organization and advanced the development of vaccines against pneumococcus, rotavirus, ETEC, shigella, meningococcus, influenza, respiratory syncytial virus, polio and Japanese encephalitis. Prior to this, he served as executive director of Biologics, Clinical Research at Merck & Co., Inc., where he directed a global team that was responsible for the successful development and licensure of a portfolio that included a Haemophilus influenzae type b conjugate vaccine, various pediatric combination vaccines, a rotavirus vaccine, and the first HPV vaccine, among others. Dr. Boslego began his career at the Walter Reed Army Medical Center and Walter Reed Army Institute of Research. He served as the Director of the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand where he led research and development programs for treatments and vaccines against hepatitis A, malaria, dengue, rickettsial diseases, bacterial diarrheas, and HIV. Dr. Boslego’s final assignment in the US Army was as Deputy Director of the Walter Reed Army Institute of Research (WRAIR), where he directed research and vaccine development against a broad array of viral, bacterial and parasitic pathogens. Dr. Boslego received his medical degree from the George Washington University School of Medicine in Washington, DC and completed specialty training in Internal Medicine and Infectious Diseases.